COMBINATION THERAPY WITH GLATIRAMER ACETATE AND ALPHACALCIDOL FOR THE TREATMENT OF MULTIPLE SCLEROSIS
The subject invention provides a method of treating a subject afflicted with a form of multiple sclerosis comprising periodically administering to the subject an amount of glatiramer acetate and an amount of alphacalcidol, wherein the amounts when taken together are effective to alleviate a symptom...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
28.10.2004
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The subject invention provides a method of treating a subject afflicted with a form of multiple sclerosis comprising periodically administering to the subject an amount of glatiramer acetate and an amount of alphacalcidol, wherein the amounts when taken together are effective to alleviate a symptom of the form of multiple sclerosis in the subject so as to thereby treat the subject. The subject invention also provides a package comprising glatiramer acetate, alphacalcidol and instructions for use of the together to alleviate a symptom of a form of multiple sclerosis in a subject. Additionally, the subject invention provides a pharmaceutical composition comprising an amount of glatiramer acetate and an amount of alphacalcidol, wherein the amounts wh en taken together are effective to alleviate a symptom of a form of multiple sclerosis in a subject. The subject invention further provides a pharmaceutical combination comprising separate dosage forms of an amount of glatiramer acetate and an amount of alphacalcidol, which combination is usef ul to alleviate a symptom of a form of multiple sclerosis in a subject. |
---|---|
Bibliography: | Application Number: CA20042518079 |